Meridian Bioscience Gets FDA Re-authorization Of EUA For Revogene SARS-CoV-2 Molecular Assay

RTTNews | hace 1059
Meridian Bioscience Gets FDA Re-authorization Of EUA For Revogene SARS-CoV-2 Molecular Assay

(RTTNews) - Diagnostic testing provider Meridian Bioscience, Inc. (VIVO) announced Friday that it received re-authorization of its Emergency Use Authorization (EUA) for the Revogene SARS-COV-2 molecular assay from the U.S. Food and Drug Administration (FDA).

Meridian expects to begin shipping this product before the end of its fiscal fourth quarter, ending September 30, 2022.

On November 10, 2021, Meridian announced the Revogene SARS-CoV-2 assay was granted authorization by the FDA. Subsequent to that, it was determined that the original design of the assay would not detect the Omicron variant.

Over the last few months in consultation with the FDA, Meridian completed additional clinical studies and the FDA has now re-authorized the EUA.

For More Such Health News, visit rttnews.com

read more
China Shares May Open Under Pressure On Monday

China Shares May Open Under Pressure On Monday

The China stock market has moved lower in back-to-back sessions, shedding almost 30 points or 0.9 percent in that span. The Shanghai Composite Index now sits just shy of the 3,360-point plateau and it may extend its losses again on Monday.
RTTNews | hace 13 minutos
Taiwan Shares Likely To Remain Rangebound On Monday

Taiwan Shares Likely To Remain Rangebound On Monday

The Taiwan stock market bounced higher again on Friday, one day after ending the two-day winning streak in which it had risen more than 300 points or 1.3 percent. The Taiwan Stock Exchange now sits just beneath the 22,050-point plateau although they may tick lower again on Monday.
RTTNews | hace 43 minutos
Singapore Shares Tipped To Open In The Red On Monday

Singapore Shares Tipped To Open In The Red On Monday

The Singapore stock market has moved lower in three straight sessions, slumping almost 50 points or 1.3 percent along the way. The Straits Times Index now sits just above the 3,880-point plateau and it's likely to see continued selling pressure again on Monday.
RTTNews | hace 1h 13min
Little Movement Seen For Malaysia Stock Market

Little Movement Seen For Malaysia Stock Market

The Malaysia stock market has alternated between positive and negative finishes through the last six trading days since the end of the two-day winning streak in which it had gathered almost 10 points or 0.6 percent. The Kuala Lumpur Composite Index now sits just above the 1,500-point plateau and it figures to remain rangebound again on Monday.
RTTNews | hace 1h 43min
Soft Start Eyed For Japan Stock Market

Soft Start Eyed For Japan Stock Market

The Japan stock market has finished lower in back-to-back sessions, stumbling more than 480 points or 1.2 percent along the way. The Nikkei 225 now rests just above the 38,400-point plateau and it may take further damage on Monday.
RTTNews | hace 1h 58min
South Korea Bourse Overdue For Profit Taking

South Korea Bourse Overdue For Profit Taking

The South Korea stock market has climbed higher in five straight sessions, accelerating almost 130 points or 4.3 percent along the way. The KOSPI now rests just above the 3,020-point plateau for the first time in three and a half years, although investors figure to lock in gains on Monday.
RTTNews | hace 2h 13min
Singapore Inflation Data Due On Monday

Singapore Inflation Data Due On Monday

Singapore will on Monday release May figures for consumer prices, highlighting a light day for Asia-Pacific economic activity. In April, overall inflation was down 0.3 percent on month and up 0.9 percent on year, while core CPI rose an annual 0.7 percent.
RTTNews | hace 3h 13min
Euro Climbs Against Majors

Euro Climbs Against Majors

The euro firmed against its major counterparts in the New York session on Friday, as risk sentiment improved after U.S. President Donald Trump delayed decision on joining the Israel-Iran conflict.
RTTNews | hace 2